Skip to content
Screener

Raw materials at other companies

Gilead Sciences logo
Gilead SciencesGILD
$1.42B+11.3%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$5.65M
ALN
Alnylam PharmaceuticalsALNY
$13.91M-39.2%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$27.85M
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$15K-28.6%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$77.77M+21.8%

Other financials

Income statement

See full
Revenue$176.2M+37.9%
Operating income-$42.5M-753%
Net income-$67.2M-1,047%
EPS (diluted)-$1.06-783%

Balance sheet

See full
Cash & equivalents$262.7M+39.4%
Total debt$12.9M+29.2%
Total equity-$10.4M-104%
Total assets$1.0B+44.0%

Cash flow

See full
Operating cash flow-$44.3M-468%
CapEx$23.0K-81.7%
Free cash flow-$44.3M-472%

Valuation

See full
Market cap$6.14B+85.5%
Enterprise value$5.89B+88.1%
P/S9.9×+2.2×

Profitability

See full
Operating margin-134.9%-151pp
Net margin-139.2%-156pp
FCF margin-37%

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.9×-0.3×

Where this comes from

Reported directly by Mirum Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterialsAndSupplies.

The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001759425-26-000045
Line itemJune 30,2026December 31,2025
Raw materials$2,613$2,898
Work in progress20,13918,473
Finished goods3,0173,516
Total inventory$25,769$24,887

Item 1. Financial Statements (Unaudited)

FAQ

What is Mirum Pharmaceuticals, Inc.'s raw materials?
Mirum Pharmaceuticals, Inc. (MIRM) reported raw materials of $2.61M in Q2 2026.
How has Mirum Pharmaceuticals, Inc.'s raw materials changed year-over-year?
Mirum Pharmaceuticals, Inc.'s raw materials decreased by 10.6% year-over-year, from $2.92M to $2.61M.
What is the long-term trend for Mirum Pharmaceuticals, Inc.'s raw materials?
Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s raw materials has grown at a -1.7% compound annual growth rate (CAGR), from $3M to $2.9M.
What does raw materials mean?
Unprocessed materials and components purchased for use in manufacturing, valued at cost.

Ask your AI about Mirum Pharmaceuticals, Inc.'s raw materials.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude